behavioral interventional studies

BEHAVIORAL STUDIESSTUDY RESULTSAll studies with completion date in the future marked as 2018Studies with start date in 2017 and beyond removed



Study Results: Total Number of studies vs. enrolled subjects

Study results not available Has results

Study Results by Completion Date


Number of studies



Study Results by Completion Date Number of enrolled subjects


BEHAVIORAL STUDIESSTUDY PHASESAll studies with completion date in the future marked as 2018Studies with start date in 2017 and beyond removed


Behavioral Studies by Phase


Number of studies vs. enrolled subjects

Phase 0Phase 1Phase 1|2Phase 2Phase 2|3Phase 3Phase 4n/a

Number of studies




Number of enrolled subjects




BEHAVIORAL STUDIESSTUDY PURPOSEAll studies with completion date in the future marked as 2018Studies with start date in 2017 and beyond removed



Purpose of Behavioral studiesNumber of studies vs. enrolled subjects

Basic science Diagnostic Educational/Counseling/TrainingHealth Service Research Prevention Screening Supportive Care Treatment Not stated, n/a

Purpose of Behavioral studies over time


Number of studies



Number of enrolled subjectsPurpose of Behavioral studies over time


BEHAVIORAL STUDIESSTUDY ENDPOINTSAll studies with completion date in the future marked as 2018Studies with start date in 2017 and beyond removed



Endpoints of Behavioral studiesNumber of studies vs. enrolled subjects

Bio-Availability Study Bio-Equivalence Study Efficacy Study PDPK PK/PD Safety Study Safety/Efficacy Study Not stated, n/a

Endpoints of Behavioral studies



Number of studies

Endpoints of Behavioral studies




BEHAVIORAL STUDIESSTUDY FUNDINGAll studies with completion date in the future marked as 2018Studies with start date in 2017 and beyond removed



Funding of Behavioral studiesNumber of studies vs. enrolled subjects

Industry Industry & other entities NIHNIH & other entities Other Other & other entities U.S. Fed U.S. Fed & other entities

Funding of Behavioral studies



Number of studies


Funding of Behavioral studies



BEHAVIORAL STUDIESSTUDY DEMOGRAPHICSAll studies with completion date in the future marked as 2018Studies with start date in 2017 and beyond removed


Participation in Behavioral studies by gender


BothFemaleMalen/a

Number of studies

Participation in Behavioral studies by gender

BothFemaleMalen/a



BEHAVIORAL STUDIESRECRUITMENTAll studies with completion date in the future marked as 2018Studies with start date in 2017 and beyond removed



Recruitment into Behavioral studiesNumber of studies

Active, not recruiting Completed Enrolling by invitation Not yet recruiting Recruiting Suspended Terminated Unknown status Withdrawn


Recruitment into Behavioral studies

Active, not recruiting Completed Enrolling by invitation Not yet recruiting Recruiting Suspended Terminated Unknown status Withdrawn


BEHAVIORAL STUDIESSTUDY DESIGN: ALLOCATIONAll studies with completion date in the future marked as 2018Studies with start date in 2017 and beyond removed



Non-RandomizedRandomized n/a

Number of studies vs. enrolled subjects Allocation of interventions in Behavioral studies

Allocation of interventions in Behavioral studies



Number of studies


Allocation of interventions in Behavioral studiesNumber of enrolled subjects


BEHAVIORAL STUDIESSTUDY DESIGN: ASSIGNMENTAll studies with completion date in the future marked as 2018Studies with start date in 2017 and beyond removed



Number of studies vs. enrolled subjects

Crossover Factorial Parallel Single Group Not stated, n/a

Design of Behavioral studies: Assignment



Design of Behavioral studies: Assignment Number of studies


Design of Behavioral studies: Assignment



BEHAVIORAL STUDIESSTUDY RESULTS: MASKINGAll studies with completion date in the future marked as 2018Studies with start date in 2017 and beyond removed



Number of studies vs. enrolled subjects Design of Behavioral studies: Assignment

Double-BlindOpen Label Single Blind Not stated, n/a

Design of Behavioral studies: MaskingNumber of studies




Design of Behavioral studies: MaskingNumber of enrolled subjects


ARETE-ZOE, as a consultancy, provides solutions to complex problems in the high stakes and high consequence environment of Global Pharmaceuticals, including clinical research, healthcare informatics, and public health. We blend established, Pharma sector methodologies, innovation, and adaptations/transfers from other sectors to identify and resolve consequential practices that pose risk and often result in avoidable patient casualty. However, we are specifically, not a patient advocacy group but believe in optimizing organizational effectiveness and that smart business is agile, competitive and profitable, while intrinsically safe, secure, and resilient. We work within a global context because transnational interests influence national circumstances and choices at point of prescription.

ARETE-ZOE, provides full spectrum organizational and operational risk management consultancy. Our published materials provide a glimpse of some aspects of our services to demonstrate both knowledge and ongoing participation within the Pharmaceutical Industry. Our analysis and consultancy includes all channels of misuse, diversion, counterfeiting and illicit exploitation of pharmaceuticals, medical devices, and precursor chemicals. Our advisement is to manufactures, jurisdictional entities, insurers, legislators, litigators, patients, and health care providers. This scope also frequently segues into the nexus of crime and terrorism as significant influencers that undermine sector integrity differentiated from other criminal activity. Obviously, vulnerability assessment, information collection management and intelligence production supporting decision-making for risk reduction and interventions are routinely within the scope of our services as well as design and implementation of operational control measures.


behavioral interventional studies

Health & Medicine